Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma

Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology 2024, Vol.42 (16_suppl)
Hauptverfasser: Eddine O. Kacimi, Salah, Dehais, Caroline, Feuvret, Loic, Chinot, Olivier, Carpentier, Catherine, Bronnimann, Charlotte, Vauléon, Elodie, Djelad, Apolline, L. Cohen-Jonathan Moyal, Elizabeth, Langlois, Olivier, Campone, Mario, Ducloie, Mathilde, Noel, Georges, Cuzzubbo, Stefania, Ricard, Damien, Faillot, Thierry, Boëlle, Pierre-Yves, Figarella‑branger, Dominique, Ducray, François, Touat, Mehdi
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Life Sciences
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 16_suppl
container_start_page
container_title Journal of clinical oncology
container_volume 42
creator Eddine O. Kacimi, Salah
Dehais, Caroline
Feuvret, Loic
Chinot, Olivier
Carpentier, Catherine
Bronnimann, Charlotte
Vauléon, Elodie
Djelad, Apolline
L. Cohen-Jonathan Moyal, Elizabeth
Langlois, Olivier
Campone, Mario
Ducloie, Mathilde
Noel, Georges
Cuzzubbo, Stefania
Ricard, Damien
Faillot, Thierry
Boëlle, Pierre-Yves
Figarella‑branger, Dominique
Ducray, François
Touat, Mehdi
description
doi_str_mv 10.1200/jco.2024.42.16_suppl.2004
format Article
fullrecord <record><control><sourceid>hal</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04614653v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_04614653v1</sourcerecordid><originalsourceid>FETCH-hal_primary_oai_HAL_hal_04614653v13</originalsourceid><addsrcrecordid>eNqVjctKxDAYRoMoWC_vEJcu0knS27iUUangQlDEXYltpv2HNH9N0sr4KPO0tugLuPrgcA4fIVeCx0JyvtrVGEsu0ziVscgrPw6DmQFPj0gkMlmwosiyYxLxIpFMrJP3U3Lm_Y5zka6TLCKHl9FNMClDcQw19tpT5T3WoIJu6BeEjm7B-cAMWE2fN28UHQ26x2802EOjKVg6dx9gVQC0v4lTDWDotFPDfhEe70rWj0HZQMWwEjefrMZGG718tLOsaULRQDtD2zhsDWCvLsjJVhmvL__2nFw_3L9uStYpUw0OeuX2FSqoytunamE8zUWaZ8kkkv-4P0OOaEM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma</title><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Eddine O. Kacimi, Salah ; Dehais, Caroline ; Feuvret, Loic ; Chinot, Olivier ; Carpentier, Catherine ; Bronnimann, Charlotte ; Vauléon, Elodie ; Djelad, Apolline ; L. Cohen-Jonathan Moyal, Elizabeth ; Langlois, Olivier ; Campone, Mario ; Ducloie, Mathilde ; Noel, Georges ; Cuzzubbo, Stefania ; Ricard, Damien ; Faillot, Thierry ; Boëlle, Pierre-Yves ; Figarella‑branger, Dominique ; Ducray, François ; Touat, Mehdi</creator><creatorcontrib>Eddine O. Kacimi, Salah ; Dehais, Caroline ; Feuvret, Loic ; Chinot, Olivier ; Carpentier, Catherine ; Bronnimann, Charlotte ; Vauléon, Elodie ; Djelad, Apolline ; L. Cohen-Jonathan Moyal, Elizabeth ; Langlois, Olivier ; Campone, Mario ; Ducloie, Mathilde ; Noel, Georges ; Cuzzubbo, Stefania ; Ricard, Damien ; Faillot, Thierry ; Boëlle, Pierre-Yves ; Figarella‑branger, Dominique ; Ducray, François ; Touat, Mehdi</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/jco.2024.42.16_suppl.2004</identifier><language>eng</language><publisher>American Society of Clinical Oncology</publisher><subject>Cancer ; Life Sciences</subject><ispartof>Journal of clinical oncology, 2024, Vol.42 (16_suppl)</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-2910-4930 ; 0000-0002-3604-887X ; 0000-0001-6317-9691 ; 0000-0002-2208-0545 ; 0000-0001-6820-2782 ; 0000-0001-9019-9778 ; 0000-0002-5367-8232 ; 0000-0002-5196-5908 ; 0000-0003-0288-4607 ; 0000-0002-8150-5785 ; 0000-0002-5910-7799 ; 0000-0002-7673-9114 ; 0000-0002-5196-5908 ; 0000-0001-6317-9691 ; 0000-0002-5910-7799 ; 0000-0002-5367-8232 ; 0000-0003-2910-4930 ; 0000-0002-8150-5785 ; 0000-0003-0288-4607 ; 0000-0002-2208-0545 ; 0000-0001-9019-9778 ; 0000-0002-7673-9114 ; 0000-0001-6820-2782 ; 0000-0002-3604-887X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://hal.science/hal-04614653$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Eddine O. Kacimi, Salah</creatorcontrib><creatorcontrib>Dehais, Caroline</creatorcontrib><creatorcontrib>Feuvret, Loic</creatorcontrib><creatorcontrib>Chinot, Olivier</creatorcontrib><creatorcontrib>Carpentier, Catherine</creatorcontrib><creatorcontrib>Bronnimann, Charlotte</creatorcontrib><creatorcontrib>Vauléon, Elodie</creatorcontrib><creatorcontrib>Djelad, Apolline</creatorcontrib><creatorcontrib>L. Cohen-Jonathan Moyal, Elizabeth</creatorcontrib><creatorcontrib>Langlois, Olivier</creatorcontrib><creatorcontrib>Campone, Mario</creatorcontrib><creatorcontrib>Ducloie, Mathilde</creatorcontrib><creatorcontrib>Noel, Georges</creatorcontrib><creatorcontrib>Cuzzubbo, Stefania</creatorcontrib><creatorcontrib>Ricard, Damien</creatorcontrib><creatorcontrib>Faillot, Thierry</creatorcontrib><creatorcontrib>Boëlle, Pierre-Yves</creatorcontrib><creatorcontrib>Figarella‑branger, Dominique</creatorcontrib><creatorcontrib>Ducray, François</creatorcontrib><creatorcontrib>Touat, Mehdi</creatorcontrib><title>Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma</title><title>Journal of clinical oncology</title><subject>Cancer</subject><subject>Life Sciences</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVjctKxDAYRoMoWC_vEJcu0knS27iUUangQlDEXYltpv2HNH9N0sr4KPO0tugLuPrgcA4fIVeCx0JyvtrVGEsu0ziVscgrPw6DmQFPj0gkMlmwosiyYxLxIpFMrJP3U3Lm_Y5zka6TLCKHl9FNMClDcQw19tpT5T3WoIJu6BeEjm7B-cAMWE2fN28UHQ26x2802EOjKVg6dx9gVQC0v4lTDWDotFPDfhEe70rWj0HZQMWwEjefrMZGG718tLOsaULRQDtD2zhsDWCvLsjJVhmvL__2nFw_3L9uStYpUw0OeuX2FSqoytunamE8zUWaZ8kkkv-4P0OOaEM</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Eddine O. Kacimi, Salah</creator><creator>Dehais, Caroline</creator><creator>Feuvret, Loic</creator><creator>Chinot, Olivier</creator><creator>Carpentier, Catherine</creator><creator>Bronnimann, Charlotte</creator><creator>Vauléon, Elodie</creator><creator>Djelad, Apolline</creator><creator>L. Cohen-Jonathan Moyal, Elizabeth</creator><creator>Langlois, Olivier</creator><creator>Campone, Mario</creator><creator>Ducloie, Mathilde</creator><creator>Noel, Georges</creator><creator>Cuzzubbo, Stefania</creator><creator>Ricard, Damien</creator><creator>Faillot, Thierry</creator><creator>Boëlle, Pierre-Yves</creator><creator>Figarella‑branger, Dominique</creator><creator>Ducray, François</creator><creator>Touat, Mehdi</creator><general>American Society of Clinical Oncology</general><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-2910-4930</orcidid><orcidid>https://orcid.org/0000-0002-3604-887X</orcidid><orcidid>https://orcid.org/0000-0001-6317-9691</orcidid><orcidid>https://orcid.org/0000-0002-2208-0545</orcidid><orcidid>https://orcid.org/0000-0001-6820-2782</orcidid><orcidid>https://orcid.org/0000-0001-9019-9778</orcidid><orcidid>https://orcid.org/0000-0002-5367-8232</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0003-0288-4607</orcidid><orcidid>https://orcid.org/0000-0002-8150-5785</orcidid><orcidid>https://orcid.org/0000-0002-5910-7799</orcidid><orcidid>https://orcid.org/0000-0002-7673-9114</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0001-6317-9691</orcidid><orcidid>https://orcid.org/0000-0002-5910-7799</orcidid><orcidid>https://orcid.org/0000-0002-5367-8232</orcidid><orcidid>https://orcid.org/0000-0003-2910-4930</orcidid><orcidid>https://orcid.org/0000-0002-8150-5785</orcidid><orcidid>https://orcid.org/0000-0003-0288-4607</orcidid><orcidid>https://orcid.org/0000-0002-2208-0545</orcidid><orcidid>https://orcid.org/0000-0001-9019-9778</orcidid><orcidid>https://orcid.org/0000-0002-7673-9114</orcidid><orcidid>https://orcid.org/0000-0001-6820-2782</orcidid><orcidid>https://orcid.org/0000-0002-3604-887X</orcidid></search><sort><creationdate>2024</creationdate><title>Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma</title><author>Eddine O. Kacimi, Salah ; Dehais, Caroline ; Feuvret, Loic ; Chinot, Olivier ; Carpentier, Catherine ; Bronnimann, Charlotte ; Vauléon, Elodie ; Djelad, Apolline ; L. Cohen-Jonathan Moyal, Elizabeth ; Langlois, Olivier ; Campone, Mario ; Ducloie, Mathilde ; Noel, Georges ; Cuzzubbo, Stefania ; Ricard, Damien ; Faillot, Thierry ; Boëlle, Pierre-Yves ; Figarella‑branger, Dominique ; Ducray, François ; Touat, Mehdi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-hal_primary_oai_HAL_hal_04614653v13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cancer</topic><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eddine O. Kacimi, Salah</creatorcontrib><creatorcontrib>Dehais, Caroline</creatorcontrib><creatorcontrib>Feuvret, Loic</creatorcontrib><creatorcontrib>Chinot, Olivier</creatorcontrib><creatorcontrib>Carpentier, Catherine</creatorcontrib><creatorcontrib>Bronnimann, Charlotte</creatorcontrib><creatorcontrib>Vauléon, Elodie</creatorcontrib><creatorcontrib>Djelad, Apolline</creatorcontrib><creatorcontrib>L. Cohen-Jonathan Moyal, Elizabeth</creatorcontrib><creatorcontrib>Langlois, Olivier</creatorcontrib><creatorcontrib>Campone, Mario</creatorcontrib><creatorcontrib>Ducloie, Mathilde</creatorcontrib><creatorcontrib>Noel, Georges</creatorcontrib><creatorcontrib>Cuzzubbo, Stefania</creatorcontrib><creatorcontrib>Ricard, Damien</creatorcontrib><creatorcontrib>Faillot, Thierry</creatorcontrib><creatorcontrib>Boëlle, Pierre-Yves</creatorcontrib><creatorcontrib>Figarella‑branger, Dominique</creatorcontrib><creatorcontrib>Ducray, François</creatorcontrib><creatorcontrib>Touat, Mehdi</creatorcontrib><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eddine O. Kacimi, Salah</au><au>Dehais, Caroline</au><au>Feuvret, Loic</au><au>Chinot, Olivier</au><au>Carpentier, Catherine</au><au>Bronnimann, Charlotte</au><au>Vauléon, Elodie</au><au>Djelad, Apolline</au><au>L. Cohen-Jonathan Moyal, Elizabeth</au><au>Langlois, Olivier</au><au>Campone, Mario</au><au>Ducloie, Mathilde</au><au>Noel, Georges</au><au>Cuzzubbo, Stefania</au><au>Ricard, Damien</au><au>Faillot, Thierry</au><au>Boëlle, Pierre-Yves</au><au>Figarella‑branger, Dominique</au><au>Ducray, François</au><au>Touat, Mehdi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma</atitle><jtitle>Journal of clinical oncology</jtitle><date>2024</date><risdate>2024</risdate><volume>42</volume><issue>16_suppl</issue><issn>0732-183X</issn><eissn>1527-7755</eissn><pub>American Society of Clinical Oncology</pub><doi>10.1200/jco.2024.42.16_suppl.2004</doi><orcidid>https://orcid.org/0000-0003-2910-4930</orcidid><orcidid>https://orcid.org/0000-0002-3604-887X</orcidid><orcidid>https://orcid.org/0000-0001-6317-9691</orcidid><orcidid>https://orcid.org/0000-0002-2208-0545</orcidid><orcidid>https://orcid.org/0000-0001-6820-2782</orcidid><orcidid>https://orcid.org/0000-0001-9019-9778</orcidid><orcidid>https://orcid.org/0000-0002-5367-8232</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0003-0288-4607</orcidid><orcidid>https://orcid.org/0000-0002-8150-5785</orcidid><orcidid>https://orcid.org/0000-0002-5910-7799</orcidid><orcidid>https://orcid.org/0000-0002-7673-9114</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0001-6317-9691</orcidid><orcidid>https://orcid.org/0000-0002-5910-7799</orcidid><orcidid>https://orcid.org/0000-0002-5367-8232</orcidid><orcidid>https://orcid.org/0000-0003-2910-4930</orcidid><orcidid>https://orcid.org/0000-0002-8150-5785</orcidid><orcidid>https://orcid.org/0000-0003-0288-4607</orcidid><orcidid>https://orcid.org/0000-0002-2208-0545</orcidid><orcidid>https://orcid.org/0000-0001-9019-9778</orcidid><orcidid>https://orcid.org/0000-0002-7673-9114</orcidid><orcidid>https://orcid.org/0000-0001-6820-2782</orcidid><orcidid>https://orcid.org/0000-0002-3604-887X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0732-183X
ispartof Journal of clinical oncology, 2024, Vol.42 (16_suppl)
issn 0732-183X
1527-7755
language eng
recordid cdi_hal_primary_oai_HAL_hal_04614653v1
source American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Cancer
Life Sciences
title Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A35%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survival%20outcomes%20associated%20with%20first-line%20PCV%20or%20temozolomide%20in%20combination%20with%20radiotherapy%20in%20IDH-mutant%201p/19q-codeleted%20grade%203%20oligodendroglioma&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=Eddine%20O.%20Kacimi,%20Salah&rft.date=2024&rft.volume=42&rft.issue=16_suppl&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/jco.2024.42.16_suppl.2004&rft_dat=%3Chal%3Eoai_HAL_hal_04614653v1%3C/hal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true